Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• The Customer is Sometimes Right: Direct-to-consumer Ads in Rheumatology
• Ace the Case: A 76-Year-Old Female With White Discoloration of Fingers
• Formulary Construction in America: ‘Perfectly Legal’ and ‘Perfectly Wrong’ Madelaine A. Feldman, MD, FACR
• Arthritis Foundation Issues First CBD Guidance for Adults With Arthritis
• Disease Burden, Prescription Use High in Patients With Both Knee, Hip OA
• Newly Diagnosed Cases of AS at Increased Risk for IMIDs, Lower Risk for RA
• Rheumatologists Value Patient-reported RA Symptoms Over Test Results
• Tocilizumab Increases HDL, LDL Cholesterol, Triglycerides Compared With Etanercept in RA
• Young Adults With Chronic Diseases Report More Daily Marijuana Use
• Infusion Reactions to Rituximab More Significant in SLE Than Other Diseases
• Nearly 60% of Rheumatology Patients Struggle to Afford Treatment
• Addressing Arthritis Pain Without the Opioids Physicians ‘Love to Hate’
• Cyclophosphamide ‘Not Dead Yet’ for ANCA-associated Vasculitis
• Handheld Dynamometry Effective for Muscle Strength Assessment in Polymyositis
• Reconsidering, Retiring the Controversial ‘Lupus Headache’
• Rheumatologists Challenged to Embrace Nonoperative Options for OA
• Sepsis, Pneumonia Leading Causes of Readmission in ANCA-associated Vasculitis
• Four Strategies for Improving on ‘Crummy’ Gout Management
• T Follicular Helper Cells Linked to Active RA Development
• Rheumatologist Input Absent in Disputed Hydroxychloroquine Guidelines
• Onsite With Loyola Medicine: Chicagoland Rheumatologists Work to Close the Rural Health Care Gap
• Q&A: Gluten-free Diet Unlikely to Prevent Psoriatic Diseases, Atopic Dermatitis
• Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Discontinuation
• Prior Authorization Linked to Treatment Delays
• Sprifermin Shows ‘Positive Sign’ for Cartilage Thickness in Knee OA